Fig. 1

Study design flowchart. Twenty-one percent of the patients treated with TACE met the eligibility criteria, which is also the criteria for SABR with curative intent in our institute. These patients were divided into 4 groups according to the further treatment received. Abbreviations: HCC, hepatocellular carcinoma; TACE, transcatheter arterial chemoembolization; Tx, treatment; SABR, stereotactic ablative radiotherapy. * Percentage of patients from the total number of patients receiving TACE (n = 832). † Percentage of patients from those meeting the eligibility criteria (n = 178)